La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Eledon Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Eledon Pharmaceuticals..

Eledon Pharmaceuticals (NASDAQ:ELDN) Azioni, Catena delle Opzioni

Eledon Pharma

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

WIIM

ACTU

ACTU stock has given up its prior gain. Actuate Therapeutics shares were trading higher after the company announced elraglusib combined with GnP met its primary endpoint in its ongoing Phase 2 trial.

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and raises the price target from $29 to $30.

News

Price Target

Analyst Ratings

EVER

JP Morgan Maintains Overweight on EverQuote, Raises Price Target to $30

JP Morgan analyst Stephen Tusa maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Overweight and raises the price target from $289 to $300.

JP Morgan Maintains Overweight on Eaton Corp, Raises Price Target to $300

JP Morgan analyst Tami Zakaria maintains Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) with a Neutral and raises the price target from $308 to $320.

JP Morgan Maintains Neutral on Cummins, Raises Price Target to $320

Comstock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LODE#NYSE">LODE</a>) announced today that its subsidiary, Comstock Metals LLC ("Comstock Metals"), a pioneer in sustainable, zero-landfill solar panel recycling is the first solar panel recycling company in North America to be certified to the R2v3/RIOS Responsible Recycling Standard, and specifically to Appendix G that authenticates a zero-waste recycling process that safely repurposes each recycled material into new commercial applications. Comstock Metals has demonstrated panel processing with proprietary thermal methods, producing 100% commodity-ready products. All parts of the panel, including glass, aluminum, and fines, are fully recycled.

LODE

Comstock Metals Granted First R2v3/RIOS Certifications For Zero-Waste Solar Panel Recycling In North America

JP Morgan analyst Jessica Fye maintains BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Overweight and raises the price target from $10 to $13.

BCRX

JP Morgan Maintains Overweight on BioCryst Pharma, Raises Price Target to $13

Canada expects British Columbia to drive the <a href="https://www.benzinga.com/topic/canada">next generation of mining investments</a>.
According to the <a href="https://mining.bc.ca/2025/05/2025-economic-impact-study/">2025 Economic Impact Study</a>, 27 projects could contribute up to $90 billion in economic activity.
The report, commissioned by the Mining Association of British Columbia (MABC) and prepared by Mansfield Consulting, outlines over $41 billion in direct investments. That includes 18 critical mineral, six precious metal, and three steelmaking coal mines. 
Over their lifetimes, these ventures could contribute $984 billion in cumulative economic output.
"B.C. has the minerals, precious metals and steelmaking coal the world needs," MABC CEO Michael Goehring said in a <a href="https://mining.bc.ca/2025/05/mining-will-secure-bcs-economic-future/">prepared statement</a>.
"Mining has the potential to drive a new wave of economic growth — creating jobs, strengthening local and First Nations communities, and generating revenues for government services," he added.
British Columbia boasts nearly 277,000 jobs supported during construction and over two million jobs through operations across Canada. Developers expect the projects to contribute over $421 billion in GDP during operation within the region alone.
Over time, the activity would generate $87.8 billion in provincial taxes and $69.2 billion in federal taxes, bolstering public services. The study urges regulatory reform under newly elected Prime Minister Mark Carney.
Industry reaction to Carney's proposals has been largely positive but cautious. According to MAC President Pierre Gratton, the Mining Association of Canada (MAC) praised his platform for proposing "trade-enabling infrastructure investments, new and expanded tax measures, and support for Indigenous participation.&#8221; 
However, Carney&#8217;s ambiguity on Indigenous consent processes has raised concerns about implementation timelines, which are critical to moving projects forward responsibly and swiftly.
Australia Prime Minister Anthony Albanese faces a similar situation. The mining industry urges the re-elected PM <a href="https://www.benzinga.com/news/global/25/05/45200748/australias-miners-strike-policy-gold-with-labor-reelection-whats-next">to realign</a> with the current global market dynamic.
British Columbia's projects span a diverse resource base. Critical mineral developments include the Baptiste from FPX Nickel (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/FPOCF#OTCQB">FPOCF</a>), Seabridge Gold's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>) KSM copper-gold mine, and Giga Metals' (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/GIGGF#OTCQB">GIGGF</a>) Turnagain project.
The Baptiste project, for example, could position Canada as a leading supplier of nickel for EV batteries. Meanwhile, with 47.3 million ounces of gold, KSM is one of the largest undeveloped deposits in the world. Turnagain stands out for its carbon-efficient processing technology and potential for low-emission nickel production. Developers expect these projects to attract billions in supplier contracts and generate long-term employment, particularly in rural and Indigenous communities.
"The responsible development of BC's critical minerals, precious metals, and steelmaking coal resources can secure BC's economic future, resiliency and long-term prosperity. It's time to get more mines built," Goehring concluded.
Read Next:<a href="https://www.benzinga.com/news/guidance/25/05/45191672/bhp-lundin-venture-confirms-largest-greenfield-copper-find-in-30-years"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/05/45191672/bhp-lundin-venture-confirms-largest-greenfield-copper-find-in-30-years">BHP-Lundin Venture Confirms Largest Greenfield Copper Find In 30 Years</a></li>
</ul>
Image: Shutterstock

Government

Large Cap

Regulations

Commodities

Politics

Markets

FPOCF

GIGGF

British Columbia Mining Surge Could Add $90B To Canadian Economy: Study

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 250 points on Tuesday.
The Dow traded down 0.69% to 40,932.59 while the NASDAQ fell 0.93% to 17,678.62. The S&amp;P 500 also fell, dropping, 0.75% to 5,608.08.
Check This Out: <a href="https://www.benzinga.com/25/05/45219974/stryker-lockheed-martin-rockwell-automation-and-more-on-cnbcs-final-trades">Stryker, Lockheed Martin, Rockwell Automation And More On CNBC&#8217;s &#8216;Final Trades&#8217;</a>
Leading and Lagging Sectors Utilities shares rose by 0.7% on Tuesday.
In trading on Tuesday, health care stocks dipped by 1.1%.
Top Headline
Marriott International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) reported better-than-expected first-quarter EPS and revenue results.
Marriott reported quarterly earnings of $2.32 per share which beat the analyst consensus estimate of $2.25 per share. The company reported quarterly sales of $6.26 billion which beat the analyst consensus estimate of $6.17 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) shares shot up 211% to $1.98 after the company announced that its Myrtle recovery centers subsidiary has seen over 400 patients since August 2023.</li>
<li>Shares of Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) got a boost, surging 131% to $1.46.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares were also up, gaining 80% to $0.3252.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares dropped 64% to $0.3956 after the company announced a registered direct offering with approximately $7 million gross proceeds.</li>
<li>Shares of bioAffinity Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) were down 50% to $0.1877 after the company announced the pricing of $3.25 million offering.</li>
<li>Tactile Systems Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) was down, falling 35% to $9.08 after the company reported worse-than-expected first-quarter sales results and lowered its FY25 sales guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded up 3.6% to $59.21 while gold traded up 2.4% at $3,400.90.
Silver traded up 2.4% to $33.30 on Tuesday, while copper rose 1.3% to $4.7605.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.3%, while Spain's IBEX 35 Index fell 0.1%. Germany's DAX 40 fell 0.8% and France's CAC 40 fell 0.4% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Hong Kong's Hang Seng Index gaining 0.70%, China's Shanghai Composite Index rising 1.13% and India's BSE Sensex falling 0.19%.
Economics
The US trade deficit increased to $140.5 billion in March versus market estimates of a $137 billion gap.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Eurozone

Intraday Update

BIAF

BLMZ

FOXO

MRIN

NCNA

TCMD

Dow Falls Over 250 Points; Marriott Posts Upbeat Earnings

Benchmark analyst Daniel Kurnos maintains Gray Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTN#NYSE">GTN</a>) with a Buy and lowers the price target from $8 to $7.

Benchmark Maintains Buy on Gray Media, Lowers Price Target to $7

Global

General

Watching WK Kellogg; During Conf Call CFO Reportedly Says Co Expects Impact From Currently In Place Current Tariffs To Be Between $2M-$4M For The Full Year

Benchmark analyst Daniel Kurnos maintains Sinclair (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>) with a Buy and lowers the price target from $30 to $29.

SBGI

Benchmark Maintains Buy on Sinclair, Lowers Price Target to $29

Benchmark analyst Daniel Kurnos maintains Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) with a Buy and lowers the price target from $21 to $20.

TGNA

Benchmark Maintains Buy on Tegna, Lowers Price Target to $20

Florida has stepped back from a proposal to allow <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45058619/arizona-moving-to-convert-up-to-10-of-its-treasury-to-bitcoin-legislature-clears-bills-paving-way-for-strategic-crypto-reserve">state-managed public funds</a> to invest in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), after House Bill 487 (HB 487) was withdrawn from legislative consideration alongside its companion Senate Bill 550.
What Happened: The withdrawal was formally recorded on May 3, a day after the Florida Legislature adjourned its 2025 session, according to public records, The Block <a href="https://www.theblock.co/post/353188/florida-indefinitely-postpones-two-strategic-bitcoin-reserve-bills?utm_source=rss&amp;utm_medium=rss">reported</a>.
As a result, both bills were indefinitely postponed and withdrawn from consideration, with no vote taking place in either chamber.
House Bill 487, introduced in February 2025, sought to expand the investment authority of the Florida Chief Financial Officer (CFO) by permitting the use of state-managed investment pools for purchasing Bitcoin. 
Specifically, the bill would have amended existing statutes to include Bitcoin as a permissible investment instrument for certain surplus public funds, a move that would have placed Florida among a handful of U.S. states exploring formal crypto exposure in treasury operations.
The bill did not authorize broad crypto investments across all government funds but rather aimed to allow limited exposure under defined risk management practices.
The language in HB 487 aligned with a growing number of state-level efforts to accommodate digital assets within public-sector investment frameworks, a trend fueled by Bitcoin&#8217;s increasing adoption as an alternative store of value.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45219180/etoro-eyes-5b-valuation-in-nasdaq-ipo-sets-price-range-at-4650-per-share">eToro Eyes $5B Valuation In Nasdaq IPO, Sets Price Range At $46–$50 Per Share</a>
Why It Matters: Florida's decision to pull HB 487 follows a similar development in Arizona, where Governor Katie Hobbs recently vetoed SB 1025, a bill that would have allowed up to 10% of certain state funds to be allocated to digital assets like Bitcoin.
These setbacks come despite growing interest from lawmakers in using Bitcoin as a hedge or diversification tool within public investment strategies.
According to Bitcoin Laws, a group that tracks state-level digital asset policy, New Hampshire's HB 302 and Arizona's SB 1374 now represent the most active crypto investment legislation in the U.S.
The withdrawal of HB 487 effectively halts Florida's current push for a statutory framework around crypto investment by the state, though the topic is likely to resurface as other states advance similar efforts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45203946/binance-founder-changpeng-zhao-recounts-prison-hardships-i-was-scared-my-cellmate-had-a-sentence-for-murdering-two-guys-at-once">Binance Founder Changpeng Zhao Recounts Prison Hardships: &#8216;I Was Scared, My Cellmate Had A Sentence For Murdering Two Guys At Once&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Florida Presses Pause On Bitcoin Reserve Bill: Here's What Happened

<a href="https://www.reuters.com/sustainability/climate-energy/eu-set-out-plan-phasing-out-final-russian-gas-supplies-2025-05-06/" title="https://www.reuters.com/sustainability/climate-energy/eu-set-out-plan-phasing-out-final-russian-gas-supplies-2025-05-06/">https://www.reuters.com/sustainability/climate-energy/eu-set-out-plan-phasing-out-final-russian-gas-supplies-2025-05-06/</a>

Macro Economic Events

Econ #s

Economics

'EU Commission Says Will Propose In June To Phase Out All Remaining Russian Gas And LNG Imports By End-2027; Will Propose In June Halting Russian Gas And LNG Imports Under Long-Term Contracts By End-2027; Will Propose In June Banning Russian Gas And LNG Imports Under New Deals And Existing Spot Contracts By End-2025; Will Propose In June Restrictions On New Russian Nuclear Fuel Contracts Co-Signed By Euratom Supply Agency' - Reuters News

Benchmark analyst Daniel Kurnos maintains Nexstar Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXST#NASDAQ">NXST</a>) with a Buy and lowers the price target from $225 to $215.

NXST

Benchmark Maintains Buy on Nexstar Media Gr, Lowers Price Target to $215

CAIRO, May 6 (Reuters) - Saudi Arabia is set to discuss and sign a deal with the U.S. in the fields of mining and mineral resources, the Saudi cabinet said in a statement relayed by the country's state news agency on Tuesday.

'Saudi Arabia, U.S. To Sign Deal In Mining, Mineral Resources, Cabinet Says' - Reuters News

Benchmark analyst Daniel Kurnos maintains Paramount Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) with a Buy and lowers the price target from $19 to $16.

PARA

Benchmark Maintains Buy on Paramount Glb, Lowers Price Target to $16

UBS analyst Ashwani Verma maintains Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Buy and raises the price target from $137 to $152.

NBIX

UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $152

FANG

Watching Diamondback Energy; Reuters Reports Co Expects Q2 Oil Production Between 866 – 900 MBOEPD; Expects 2026 Production Growth If Prices Hit $65-$70, With Lower OPEC Spare Capacity; Says No Pressure To Sell Assets; Can Be Patient Amid Down Cycle; Says $70+ Crude A Healthy Level To Bring Capital Back Into Market

UBS analyst Karl Keirstead maintains Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) with a Neutral and raises the price target from $105 to $110.

PLTR

UBS Maintains Neutral on Palantir Technologies, Raises Price Target to $110

Press Releases

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Earnings

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

ELDN

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Anika Therapeutics

Annexon

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cardiff Oncology

Cargo Therapeutics

Eledon Pharmaceuticals

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Foghorn Therapeutics

Humacyte

TuHURA Biosciences

Inhibrx Biosciences

INmune Bio

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Inventiva S.A. - American Depository Shares

Inventiva

Korro Bio

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Nanobiotix

Neurogene

Prime Medicine

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

Eledon Pharmaceuticals

Eledon Pharmaceuticals (ELDN) Opzioni

Eledon Pharmaceuticals (NASDAQ:ELDN) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO